Ildong Pharmaceutical Co., Ltd.

KRX:249420.KS

14050 (KRW) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Revenue 152,149.525151,099.707151,084.261149,530.646154,085.31146,057.623151,934.145163,633.354162,497.273159,649.718142,703.885142,514.552141,644.269133,268.92138,763.647146,817.092137,510.4138,753.961121,793.49129,779.005136,658.24129,236.946130,926.617128,240.822125,700.57119,039.346113,559.007127,962.658112,452.687106,676.463122,228.08979,115.69
Cost of Revenue 95,461.52693,968.20398,195.86999,703.95598,405.01291,953.22196,828.08102,832.18101,567.005100,143.84290,327.44184,856.1983,445.87882,063.59281,201.61685,292.38771,494.15285,443.05181,281.8169,215.32368,763.13665,851.84864,419.14963,337.27561,969.7359,026.16457,828.31864,260.99856,086.22656,244.98163,368.07940,679.494
Gross Profit 56,68857,131.50452,888.39249,826.69155,680.29854,104.40255,106.06460,801.17460,930.26859,505.87652,376.44457,658.36158,198.39151,205.32957,562.03161,524.70566,016.24853,310.90940,511.68160,563.68267,895.10463,385.09866,507.46864,903.54763,730.8460,013.18255,730.68963,701.6656,366.46150,431.48258,860.01138,436.196
Gross Profit Ratio 0.3730.3780.350.3330.3610.370.3630.3720.3750.3730.3670.4050.4110.3840.4150.4190.480.3840.3330.4670.4970.490.5080.5060.5070.5040.4910.4980.5010.4730.4820.486
Reseach & Development Expenses 10,777.50816,421.17319,273.69624,322.38826,640.84624,781.1427,450.42827,996.68430,930.13923,517.85429,831.60125,181.91118,351.0123,159.33420,333.02415,463.31811,572.00112,812.53514,253.98912,569.65211,335.52110,338.27711,484.25710,742.17310,557.20613,674.4979,061.6818,631.78,063.7047,605.4047,372.5275,134.067
General & Administrative Expenses 56,882.82958,205.4923,250.02766,873.89874,862.79168,940.8813,752.183,645.5023,324.8363,244.6053,059.2163,049.5743,171.6053,145.8882,640.0622,871.6612,795.7523,266.3563,769.3283,458.8224,077.5153,743.1944,580.0093,887.9824,304.7284,434.6724,066.9794,338.6784,345.6634,687.7113,672.0452,677.425
Selling & Marketing Expenses -11,520.227-17,601.24915,787.99918,282.67515,345.51519,227.05226,345.01525,657.02526,332.80422,768.57418,140.35321,876.47724,849.63618,101.66720,570.04421,287.96424,518.72918,583.91619,612.71922,544.15824,349.00821,301.19519,315.54724,849.72520,114.36615,742.33918,094.61520,023.93419,377.76716,264.45815,012.41413,920.76
SG&A 45,362.60240,604.24336,477.70966,873.89874,862.79168,940.88130,097.19529,302.52729,657.6426,013.17921,199.56924,926.05128,021.24121,247.55523,210.10624,159.62527,314.48121,850.27223,382.04726,002.9828,426.52325,044.38923,895.55628,737.70724,419.09420,177.01122,161.59424,362.61223,723.4320,952.16918,684.45916,598.185
Other Expenses -152,650-151,004316.287-133,747.796-149,725.582-25,014.2120,665.88722,245.88422,536.7319,262.5591,219.20355.952323.587268.42468.43757.344233.468480.22633.61-425.723119.018146.9271,376.97-195.889115.008183.039375.853385.466233.0543.63747.354151.102
Operating Expenses 56,140.1157,025.41655,751.405-66,873.898-74,862.79168,707.81178,213.5179,545.09583,124.50968,793.59269,759.70672,759.94966,517.75164,780.82963,242.45455,665.72758,519.65554,353.21258,393.75860,475.98259,545.24355,313.10956,597.46460,863.17556,077.47953,273.67750,299.92252,722.99550,379.36147,467.14848,430.09934,073.743
Operating Income 547.889106.088-2,863.013-17,047.207-19,182.493-14,836.479-23,107.446-18,743.921-22,194.241-9,287.716-18,485.285-14,939.292-8,427.305-13,683.396-5,680.4235,858.9777,496.594-1,042.303-17,882.07787.78,349.868,071.9899,910.0064,040.3737,653.3596,739.5055,430.76610,978.6645,987.1012,964.33310,429.9114,362.454
Operating Income Ratio 0.0040.001-0.019-0.114-0.124-0.102-0.152-0.115-0.137-0.058-0.13-0.105-0.059-0.103-0.0410.040.055-0.008-0.1470.0010.0610.0620.0760.0320.0610.0570.0480.0860.0530.0280.0850.055
Total Other Income Expenses Net -2,455.1462,383.375-6,808.755-28,948.989-4,827.274241.84-16,935.953-4,186.67792,370.889-117,738.331-3,410.2116,237.86918,769.439-2,191.895-8,779.441-5,766.192-542.962-1,268.305-10,329.373-8,463.815-1,144.783-1,323.925-9,674.372-997.676-654.355-578.655-1,622.823-1,706.877-709.886-899.353-306.238-471.89
Income Before Tax -1,907.2572,489.462-9,671.768-45,996.196-24,009.767-14,594.639-40,043.398-22,930.59870,176.648-127,026.047-127,186.302-8,701.42310,450.08-15,767.396-14,459.86492.7866,953.631-2,310.608-28,211.45-8,376.1157,205.0796,748.064235.6323,042.6966,999.0066,160.853,807.9449,271.7885,277.2142,064.98110,123.6733,890.563
Income Before Tax Ratio -0.0130.016-0.064-0.308-0.156-0.1-0.264-0.140.432-0.796-0.891-0.0610.074-0.118-0.1040.0010.051-0.017-0.232-0.0650.0530.0520.0020.0240.0560.0520.0340.0720.0470.0190.0830.049
Income Tax Expense 2,266.7074,396.759-10,464.591503.398423.201-3,773.69113,939.773-6,053.60419,961.774-5,501.788-32,916.429-3,274.922-1,159.889-2,885.3334,463.364-813.09706.438-1,061.608-7,658.05-3,558.5541,040.316985.4483,001.149-91.94822.689-14.405-452.5811,349.979-30.973-285.541,389.61645.927
Net Income -3,239.175-833.3221,415.996-46,022.791-23,906.63-10,820.948-53,983.171-16,876.99450,481.639-121,524.259-93,736.057-4,697.03811,609.968-12,882.063-18,923.228905.8766,247.192-1,249-20,553.401-4,817.5626,164.7635,762.616-2,765.5173,134.6356,176.3176,175.2554,260.5257,921.8095,308.1872,350.5218,734.0573,844.636
Net Income Ratio -0.021-0.0060.009-0.308-0.155-0.074-0.355-0.1030.311-0.761-0.657-0.0330.082-0.097-0.1360.0060.045-0.009-0.169-0.0370.0450.045-0.0210.0240.0490.0520.0380.0620.0470.0220.0710.049
EPS -115.96-29.8350.69-1,710.92-892.53-403.99-2,015.4-630.081,885-4,862.14-3,941.03-197488-542-795.6338262-52-863.97-193.33251.43230.48-116.23125.17247.62246.71179.05317.75212.9994.37366.13169.22
EPS Diluted -115.96-29.8350.69-1,710.92-892.53-403.99-2,015.4-630.081,884.68-4,862.1-3,940.92-354128-542-795.5838262-52-863.97-193.33251.43230.48-116.23125.17247.62246.71179.05317.75212.9994.37366.13169.22
EBITDA 7,186.2156,385.6943,823.48749,826.69155,680.29854,104.402-14,147.476-12,015.149-15,501.911-1,888.517-9,666.663-7,275.76-804.265-5,874.4671,167.53213,205.94414,839.9146,510.272-10,518.7066,263.25115,538.51815,380.14517,478.8519,946.72713,846.99912,644.36610,705.05616,055.81410,751.397,450.04715,665.4854,833.449
EBITDA Ratio 0.0470.0420.0250.3330.3610.37-0.093-0.073-0.095-0.012-0.068-0.051-0.006-0.0440.0080.090.1080.047-0.0860.0480.1140.1190.1340.0780.110.1060.0940.1250.0960.070.1280.061